Susan Hill, Mestag Therapeutics CEO
Merck partners with small UK biotech to drug fibroblasts for fibrosis, I&I diseases
As Merck builds out its immunology research lab in London, it’s partnering with a local biotech startup that has remained relatively quiet …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
